ENTRADA THERAPEUTICS, INC. (TRDA) Net margin 2023–2025
ENTRADA THERAPEUTICS, INC. (TRDA) net profit margin by fiscal year — reported net income divided by reported revenue.
-565.5%FY2025 · since FY2023: -5.2% → -565.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -565.5% | -596.6 pp |
| FY2024 | 31.1% | +36.3 pp |
| FY2023 | -5.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TRDA financial trends
TRDA RevenueTRDA Net incomeTRDA Gross profitTRDA Gross marginTRDA Operating incomeTRDA Operating marginTRDA Operating cash flowTRDA Free cash flowTRDA Capital expendituresTRDA Return on equityTRDA Stock buybacksTRDA Dividends paidTRDA Total assetsTRDA Total liabilitiesTRDA Shareholders’ equityTRDA overview →